Neglected tropical diseases, malaria, and tuberculosis affect the lives of more than one billion people worldwide. These diseases impact the most impoverished and disadvantaged populations, mostly in developing countries.

The world urgently needs new and improved drugs, vaccines, and diagnostics

Partnerships between non-profit, academic, pharmaceutical and biotechnology organizations are becoming more common in the neglected tropical disease fields. Still there are many more researchers and projects that could benefit from the sharing of intellectual property, know-how and knowledge within these research organizations.

WIPO Re:Search is one way to accelerate product development for neglected tropical diseases

WIPO Re:Search is an initiative led by the World Intellectual Property Organization (WIPO) in partnership with BIO Ventures for Global Health (BVGH), and its Members. This Consortium includes a number of the world’s leading pharmaceutical companies, research institutions, governmental, and non-governmental organizations.

Through WIPO Re:Search, public and private sector organizations make valuable intellectual property and other resources available to qualified neglected tropical disease researchers anywhere in the world. WIPO Re:Search Members are working to develop new products to prevent, diagnose and treat neglected tropical diseases, malaria, and tuberculosis.

Members’ contributions are captured in a searchable, public database. These contributions include intellectual property and know-how for neglected tropical disease research including compounds, compound libraries, hits to lead series data, vaccine and diagnostic technologies, and other assets.

With these valuable resources, WIPO Re:Search aims to facilitate new partnerships between member organizations that will advance research on drugs, vaccines, and diagnostics for neglected tropical diseases, malaria and tuberculosis.

BIO Ventures for Global Health plays a pivotal role in WIPO Re:Search as the Partnership Hub Administrator. 

BVGH actively identifies partnership opportunities between members and facilitates collaborations to accelerate the development of new products for neglected tropical diseases, malaria, and tuberculosis.